Madrigal Pharmaceuticals, Inc. (MDGL) - Latest Market Data

Track the most recent price, market cap, volume, and performance data for Madrigal Pharmaceuticals, Inc. (MDGL).

Download S&P Stocks on Google Play Download S&P Stocks on the App Store

Equity Overview

Price & Market Data

Price: $294.6

Daily Change: -$4.93 / 1.67%

Range: $291.2 - $307.5

Market Cap: $6,802,647,040

Volume: 304,717

Performance Metrics

1 Week: -6.61%

1 Month: -6.15%

3 Months: -11.45%

6 Months: -12.73%

1 Year: 35.18%

YTD: -4.51%

Company Details

Employees: 528

Sector: Health technology

Industry: Pharmaceuticals: major

Country: United States

Details

Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company is headquartered in West Conshohocken, Pennsylvania.

Selected stocks

SiTime Corporation (SITM)

Regal Rexnord Corporation (RRX)

LivaNova PLC (LIVN)